ATEX - CIK 0001304492
The table below shows Anterix Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$29.26M | $41.99M | -$27.25M | $17.91M | -$9.96M | -$27.82M |
| Capital expenditure | $87.00K | $307.00K | $2.13M | $1.05M | $230.00K | $464.00K |
| Investing cash flow | $22.75M | $8.09M | -$27.13M | -$27.41M | -$14.17M | -$7.56M |
| Dividends paid | - | - | - | - | - |
Anterix Inc. reported operating cash flow of -$29.26M for fiscal year 2025. That is down 169.7% from $41.99M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$19.79M (FY 2016) to -$29.26M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $8.40M | $24.68M | $8.22M | $14.96M | $0.00 | $0.00 |
| Financing cash flow | -$6.59M | -$25.14M | -$8.06M | -$2.42M | $4.22M | $96.11M |